Head-to-head · Value Score
RxSpan MD vs Ro
Two GLP-1 deals, scored on the same six factors. RxSpan MD lands a Value Score of 86, Ro a 74. Here's who gives you the honest lower price — and where each one bites back.
RxSpan MD
#12 · Grade A- · Great Deal
Est. first month
$194/mo
Save ~86% vs brand-nameRo
#153 · Grade C+ · Watch List
Est. first month
Not disclosed
The verdict
RxSpan MD takes it on Value Score, 86 to 74 — an est. $194/mo first month, though we flag its pricing to watch. Ro isn't out of it: Patients who want brand-name access and insurance navigation more than a visible low price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | RxSpan MD | Ro |
|---|---|---|
| Value Score | 86 (A-) | 74 (C+) |
| Est. first month | $194/mo | Not disclosed |
| Save vs brand-name | ~86% | — |
| Semaglutide | From $194/mo | Not disclosed |
| Tirzepatide | $329/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Watch | Watch |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
RxSpan MD
A broad, physician-led menu — compounded and oral GLP-1 plus an advertised brand-name lane under a named plastic surgeon — with transparent, all-inclusive pricing from ~$194/mo (annual) across all 50 states.
Why it's a deal
- Available in all 50 states
- Transparent, all-inclusive published pricing — consult, medication, supplies, shipping, and support in one price; cancel or change plans anytime, with a low annual entry from ~$194/mo on compounded semaglutide
- Both injectable and a real oral (capsule) route, on compounded sema/tirz plus an advertised brand-name lane
- Physician-led by a named, board-certified founder (Dr. John Diaz, plastic surgeon); 24/7 unlimited messaging and coaching, free shipping
The fine print
- Compounded semaglutide/tirzepatide are not FDA-approved — not the same as Wegovy, Ozempic, or Zepbound
- Published pricing shown is for the compounded line — brand-name pricing isn't itemized
- Prescription isn't guaranteed — a provider reviews eligibility after checkout
Ro
A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.
Why it's a deal
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The fine print
- Does not publish compounded pricing up front — no way to compare the deal
- Premium positioning
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores RxSpan MD is ranked on the RxSpan MD alternatives ranking, and the same list for the other side is on alternatives to Ro.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.